From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications.
about
Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: where are we now?Toxicity evaluation following intratracheal instillation of iron oxide in a silica matrix in ratsAntifungal Activity of Amphotericin B Conjugated to Nanosized Magnetite in the Treatment of ParacoccidioidomycosisSynthesis of composite magnetic nanoparticles Fe3O4 with alendronate for osteoporosis treatmentNew simulation approach using classical formalism to water nuclear magnetic relaxation dispersions in presence of superparamagnetic particles used as MRI contrast agents.Effect of the nanoparticle synthesis method on dendronized iron oxides as MRI contrast agents.T1-T2 Dual-modal MRI contrast agents based on superparamagnetic iron oxide nanoparticles with surface attached gadolinium complexes.Facile integration of multiple magnetite nanoparticles for theranostics combining efficient MRI and thermal therapy.Physiological origin of biogenic magnetic nanoparticles in health and disease: from bacteria to humans.Compare analysis for the nanotoxicity effects of different amounts of endocytic iron oxide nanoparticles at single cell level.A new ex vivo method to evaluate the performance of candidate MRI contrast agents: a proof-of-concept study.Hybrid gold-iron oxide nanoparticles as a multifunctional platform for biomedical applicationComparison of T2 and T2*-weighted MR molecular imaging of a mouse model of gliomaPotentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs.Colloidal assemblies of oriented maghemite nanocrystals and their NMR relaxometric properties.Optimization of synthesis and peptization steps to obtain iron oxide nanoparticles with high energy dissipation rates.Molecular Imaging with MRI: Potential Application in Pancreatic Cancer.Targeted delivery of tissue plasminogen activator by binding to silica-coated magnetic nanoparticle.Facile One-pot Transformation of Iron Oxides from Fe2O3 Nanoparticles to Nanostructured Fe3O4@C Core-Shell Composites via Combustion Waves.Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine.Synthesis of Micelles Guided Magnetite (Fe3O4) Hollow Spheres and their application for AC Magnetic Field Responsive Drug ReleaseModulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake.Nanocarrier systems for delivery of siRNA to ovarian cancer tissues.Magnetite nanostructures as novel strategies for anti-infectious therapy.Nanomedicine strategies for hematological malignancies: what is next?Inorganic nanovectors for nucleic acid delivery.Antiapoptotic Bcl-2 protein as a potential target for cancer therapy: A mini review.Current investigations into magnetic nanoparticles for biomedical applications.Chitosan magnetic nanoparticles for drug delivery systems.Multimodal iron oxide (Fe3O4)-saturated lactoferrin nanocapsules as nanotheranostics for real-time imaging and breast cancer therapy of claudin-low, triple-negative (ER(-)/PR(-)/HER2(-)).Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging.Targeting FR-expressing cells in ovarian cancer with Fab-functionalized nanoparticles: a full study to provide the proof of principle from in vitro to in vivo.In Vitro and In Vivo Differences in Murine Third Complement Component (C3) Opsonization and Macrophage/Leukocyte Responses to Antibody-Functionalized Iron Oxide Nanoworms.Development of multiple stimuli responsive magnetic polymer nanocontainers as efficient drug delivery systems.Nanozyme applications in biology and medicine: an overview.Magnetic nanobeads decorated with silver nanoparticles as cytotoxic agents and photothermal probes.Nanoparticle microinjection and Raman spectroscopy as tools for nanotoxicology studies.Magnetic nanobeads decorated by thermo-responsive PNIPAM shell as medical platforms for the efficient delivery of doxorubicin to tumour cells.Biodistribution and biocompatibility of DMSA-stabilized maghemite magnetic nanoparticles in nonhuman primates (Cebus spp.).Dilemmas in the reliable estimation of the in-vitro cell viability in magnetic nanoparticle engineering: which tests and what protocols?
P2860
Q26739877-987FDCD4-2A31-4363-82D7-C81B47A8EEB7Q28387666-C1265F7D-2562-4163-9CCA-308916A4974CQ28550277-8CB8DB96-9CF6-49BF-A42B-60C0325DF86CQ28829845-4114B04D-C87C-4B58-8489-FFA0E507468DQ30569793-6D230618-679E-443A-9771-8303BF0D0FBAQ30578684-6B5DB453-1A42-4D4E-A23B-1C40F405BAA8Q30862611-4406F527-0D12-4E89-BAE7-82FA48EC5227Q30884196-08CD85DB-78C8-43BE-8E13-44229CF5FFE3Q33365647-4B1CF5BE-C756-41B5-8F77-CB2D0A3CBD81Q33604278-BD406907-A211-4099-9950-2DD933A44B29Q33614436-12CBFA74-815D-4D22-A212-934E9582E24AQ34316563-48DB58F5-2D89-4029-BBE7-076C8D330308Q34833006-1DDE54FA-D42E-4801-AE29-3090595B334CQ35013281-50054F5D-17B8-4857-8926-D7ABA92F4D8BQ35150598-729CB7A8-49E0-41E6-8E37-05487E033199Q35933164-ACEE2041-7532-489E-91F1-B6B63B2E5E6CQ36249508-5E535A19-4638-4A6B-9E6B-9C36C0CA894EQ36295006-3F6331B9-7571-4648-8527-165675C624FBQ36606014-12A0B2C5-164A-4194-B816-2BAFEBC4A8D8Q36615170-6E53E4ED-654C-4F70-BCAE-6B7851648737Q37379441-ADEC0521-8B33-43B0-AF20-91C66BD8199FQ37577978-E1101C78-7764-41D9-BC2C-B5FB7443EBBAQ38015511-5A2DA767-1887-4445-B7EB-2C831E5EA5B5Q38241570-72147F27-BA1D-4D4B-AC70-A4717206FB21Q38270098-2154616A-2DA0-4030-B8B2-1DBE6A1C4523Q38383483-1E7B3AC2-F9F1-4BC8-9535-7ED3BD51D654Q38388106-EEDCC126-1576-4462-8D9F-F1701E40B303Q38700718-C2A2D0E6-D047-49E0-BA20-FBB22089BD4CQ38849973-6FA09B4D-BD04-48C3-86EF-937DC3C098BDQ38918835-D938C326-65A1-4B8C-ADFD-4075BB9E9501Q38923883-82B431AF-25A5-4B99-88DD-39EBBDEF0485Q38928745-474C304E-0F1B-4AF1-9555-D5B275802A21Q38940828-A21CD7EB-795B-43AC-8034-EC91F364DE46Q39084217-6175DFE8-6B0B-475F-B230-01176BFBC438Q39255197-F6DBBDA5-4076-4246-9E48-38009182BE3BQ39325814-DBFE11CD-D4B2-4A0C-9460-BAFF549EF04AQ39481901-C05B62EC-3D69-4E56-898A-7398AE833428Q39630968-A592A6F8-4EC0-42B0-B037-B3810BAC5F84Q39739008-6D2BA791-265D-42BF-826F-700E080AB76FQ40952005-013A88BF-F3D5-4DC6-9287-7D6893C1734F
P2860
From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
From iron oxide nanoparticles ...... d for biomedical applications.
@en
From iron oxide nanoparticles ...... d for biomedical applications.
@nl
type
label
From iron oxide nanoparticles ...... d for biomedical applications.
@en
From iron oxide nanoparticles ...... d for biomedical applications.
@nl
prefLabel
From iron oxide nanoparticles ...... d for biomedical applications.
@en
From iron oxide nanoparticles ...... d for biomedical applications.
@nl
P2093
P1476
From iron oxide nanoparticles ...... d for biomedical applications.
@en
P2093
Albert Figuerola
Liberato Manna
Riccardo Di Corato
P304
P356
10.1016/J.PHRS.2009.12.012
P577
2010-01-04T00:00:00Z